☰

Istvan Bitter

Affiliations: 
Semmelweis Egyetem, Hungary 
Area:
Pharmacy, Clinical Psychology
Google:
"Istvan Bitter"
Mean distance: 21373.2
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Ferenc Martenyi grad student 2005 Semmelweis Egyetem
Czobor Pal grad student 2006 Semmelweis Egyetem
Marta Farkas grad student 2008 Semmelweis Egyetem
Viktoria Simon grad student 2009 Semmelweis Egyetem

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Papp S, Tombor L, Kakuszi B, et al. (2023) Electrophysiological underpinnings of dysfunctional inhibitory control in adults with attention-deficit/hyperactivity disorder: evidence for reduced NoGo anteriorization. Journal of Neural Transmission (Vienna, Austria : 1996)
Papp S, Tombor L, Kakuszi B, et al. (2020) Impaired early information processing in adult ADHD: a high-density ERP study. Bmc Psychiatry. 20: 292
Baradits M, Bitter I, Czobor P. (2020) Multivariate patterns of EEG microstate parameters and their role in the discrimination of patients with schizophrenia from healthy controls. Psychiatry Research. 288: 112938
Kakuszi B, Szuromi B, Bitter I, et al. (2020) Attention deficit hyperactivity disorder: Last in, first out - delayed brain maturation with an accelerated decline? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 34: 65-75
Arteaga-Henríquez G, Rosales-Ortiz SK, Arias-Vásquez A, et al. (2020) Treating impulsivity with probiotics in adults (PROBIA): study protocol of a multicenter, double-blind, randomized, placebo-controlled trial. Trials. 21: 161
Bugarski-Kirola D, Nunez R, Odetalla R, et al. (2020) T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT Schizophrenia Bulletin. 46: S247-S247
Corponi F, Fabbri C, Bitter I, et al. (2019) Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Mucci A, Vignapiano A, Bitter I, et al. (2019) A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Bitter I, Mohr P, Balogh L, et al. (2019) ADHD: a hidden comorbidity in adult psychiatric patients. Attention Deficit and Hyperactivity Disorders. 11: 83-89
Bitter I, Lieberman JA, Gaudoux F, et al. (2019) Randomized, double-blind, placebo-controlled study of F17464, a preferential D antagonist, in the treatment of acute exacerbation of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
See more...